Related references
Note: Only part of the references are listed.Serum folate receptor alpha as a biomarker for ovarian cancer: Implications for diagnosis, prognosis and predicting its local tumor expression
Akira Kurosaki et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Mesothelin-Targeted CARs: Driving T Cells to Solid Tumors
Aurore Morello et al.
CANCER DISCOVERY (2016)
Copy number deletion of RAD50 as predictive marker of BRCAness and PARP inhibitor response in BRCA wild type ovarian cancer
Min Zhang et al.
GYNECOLOGIC ONCOLOGY (2016)
Immune checkpoint inhibition in ovarian cancer
Junzo Hamanishi et al.
INTERNATIONAL IMMUNOLOGY (2016)
Effect of steroid hormones, estrogen and progesterone, on epithelial mesenchymal transition in ovarian cancer development
So-Ye Jeon et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2016)
Association and prognostic significance of BRCA1/2-mutation status with neoantigen load, number of tumor-infiltrating lymphocytes and expression of PD-1/PD-L1 in high grade serous ovarian cancer
Kyle C. Strickland et al.
ONCOTARGET (2016)
PARP inhibitors in ovarian cancer: Clinical evidence for informed treatment decisions
Jonathan A. Ledermann et al.
BRITISH JOURNAL OF CANCER (2015)
Infiltration of dendritic cells and T lymphocytes predicts favorable outcome in epithelial ovarian cancer
Z. Zhang et al.
CANCER GENE THERAPY (2015)
The role of exosomes and exosomal shuttle microRNA in tumorigenesis and drug resistance
Lei Zhao et al.
CANCER LETTERS (2015)
HE4 in the differential diagnosis of ovarian masses
Teresa Granato et al.
CLINICA CHIMICA ACTA (2015)
Olaparib: an oral PARP-1 and PARP-2 inhibitor with promising activity in ovarian cancer
Camille C. Gunderson et al.
FUTURE ONCOLOGY (2015)
The impact of pleural disease on the management of advanced ovarian cancer
Cecilia Escayola et al.
GYNECOLOGIC ONCOLOGY (2015)
Development of a multiparameter flow cytometric assay as a potential biomarker for homologous recombination deficiency in women with high-grade serous ovarian cancer
Jung-Min Lee et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
M-CSF in a new biomarker panel with HE4 and CA 125 in the diagnostics of epithelial ovarian cancer patients
Grazyna Ewa Bedkowska et al.
JOURNAL OF OVARIAN RESEARCH (2015)
Targeting myeloid cells in the tumor microenvironment enhances vaccine efficacy in murine epithelial ovarian cancer
Anm Nazmul H. Khan et al.
ONCOTARGET (2015)
Diagnosis of ovarian cancer
Sudha Sundar et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Diagnosis of ovarian cancer
Sudha Sundar et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Association of Somatic Mutations of ADAMTS Genes With Chemotherapy Sensitivity and Survival in High-Grade Serous Ovarian Carcinoma
Yuexin Liu et al.
JAMA ONCOLOGY (2015)
Contributions of the Epidermal Growth Factor Receptor to Acquisition of Platinum Resistance in Ovarian Cancer Cells
Michaela L. Granados et al.
PLOS ONE (2015)
Serum concentrations of HE4 change little during in vitro fertilization
Marianne Hallamaa et al.
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2014)
miR-335 Represents an Independent Prognostic Marker in Epithelial Ovarian Cancer
Jin Cao et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2014)
MicroRNAs in Cancer
Gianpiero Di Leva et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 9 (2014)
Evaluation of serum mesothelin in malignant and benign ovarian masses
Moustafa Ibrahim et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2014)
Increased serum level of epidermal growth factor receptor (EGFR) is associated with poor progression-free survival in patients with epithelial ovarian cancer
Faruk Tas et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2014)
Exosome-derived miRNAs and ovarian carcinoma progression
Olga Vaksman et al.
CARCINOGENESIS (2014)
Metastasis of ovarian cancer is mediated by kallikrein related peptidases
Ying Dong et al.
CLINICAL & EXPERIMENTAL METASTASIS (2014)
MicroRNA-25 expression level is an independent prognostic factor in epithelial ovarian cancer
X. Wang et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2014)
Tumor-Infiltrating Lymphocytes Expressing the Tissue Resident Memory Marker CD103 Are Associated with Increased Survival in High-Grade Serous Ovarian Cancer
John R. Webb et al.
CLINICAL CANCER RESEARCH (2014)
The Combination of Circulating Ang1 and Tie2 Levels Predicts Progression-Free Survival Advantage in Bevacizumab-Treated Patients with Ovarian Cancer
Alison Backen et al.
CLINICAL CANCER RESEARCH (2014)
Prognostic importance of cell-free DNA in chemotherapy resistant ovarian cancer treated with bevacizumab
Karina Dahl Steffensen et al.
EUROPEAN JOURNAL OF CANCER (2014)
Overexpression of SMARCE1 is associated with CD8+T-cell infiltration in early stage ovarian cancer
Antonis Giannakakis et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2014)
Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
Roy S. Herbst et al.
NATURE (2014)
Role of osteopontin in the pathophysiology of cancer
Lalita A. Shevde et al.
MATRIX BIOLOGY (2014)
Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
Alexandra Snyder et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
MicroRNA-150 Predicts a Favorable Prognosis in Patients with Epithelial Ovarian Cancer, and Inhibits Cell Invasion and Metastasis by Suppressing Transcriptional Repressor ZEB1
Minfei Jin et al.
PLOS ONE (2014)
Ovarian cancer stem cells express ROR1, which can be targeted for anti-cancer-stem-cell therapy
Suping Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Kallikrein family proteases KLK6 and KLK7 are potential early detection and diagnostic biomarkers for serous and papillary serous ovarian cancer subtypes
Ayala Tamir et al.
JOURNAL OF OVARIAN RESEARCH (2014)
The Role of MicroRNAs in Ovarian Cancer
Yasuto Kinose et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Proteomics Analysis for Finding Serum Markers of Ovarian Cancer
Yushan Cheng et al.
BIOMED RESEARCH INTERNATIONAL (2014)
HLA-G Expression Is an Independent Predictor for Improved Survival in High Grade Ovarian Carcinomas
M. J. Rutten et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2014)
Roles of exosomes and microvesicles in disease pathogenesis
Shin-ichiro Ohno et al.
ADVANCED DRUG DELIVERY REVIEWS (2013)
Identification of Serum MicroRNA-21 as a Biomarker for Early Detection and Prognosis in Human Epithelial Ovarian Cancer
Yun-Zhao Xu et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2013)
MiR-145 is downregulated in human ovarian cancer and modulates cell growth and invasion by targeting p70S6K1 and MUC1
Huijuan Wu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Integrated Analyses Identify a Master MicroRNA Regulatory Network for the Mesenchymal Subtype in Serous Ovarian Cancer
Da Yang et al.
CANCER CELL (2013)
Hormonal and Reproductive Risk Factors for Epithelial Ovarian Cancer by Tumor Aggressiveness
Elizabeth M. Poole et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2013)
miRNA Landscape in Stage I Epithelial Ovarian Cancer Defines the Histotype Specificities
Enrica Calura et al.
CLINICAL CANCER RESEARCH (2013)
Plasma MicroRNAs as Novel Biomarkers for Endometriosis and Endometriosis-Associated Ovarian Cancer
Swati Suryawanshi et al.
CLINICAL CANCER RESEARCH (2013)
Cancer stem cells in solid tumors: an overview and new approaches for their isolation and characterization
Virginia Tirino et al.
FASEB JOURNAL (2013)
Prognostic Significance of Serum Soluble CD163 Level in Patients with Epithelial Ovarian Cancer
Jae Hong No et al.
GYNECOLOGIC AND OBSTETRIC INVESTIGATION (2013)
A multiplex methylation-specific PCR assay for the detection of early-stage ovarian cancer using cell-free serum DNA
Qing Zhang et al.
GYNECOLOGIC ONCOLOGY (2013)
Fallopian tube precursors of ovarian low- and high-grade serous neoplasms
Russell Vang et al.
HISTOPATHOLOGY (2013)
Detection of MicroRNA as Novel Biomarkers of Epithelial Ovarian Cancer From the Serum of Ovarian Cancer Patient
Ye-Won Chung et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2013)
Markers of Response for the Antiangiogenic Agent Bevacizumab
Diether Lambrechts et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Serum microRNA-92 expression in patients with ovarian epithelial carcinoma
Fengjun Guo et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2013)
Prognostic significance of serum microRNA-221 expression in human epithelial ovarian cancer
Fanzhen Hong et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2013)
Role of osteopontin in differential diagnosis of ovarian tumors
Rafal Moszynski et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (2013)
Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA
Muhammed Murtaza et al.
NATURE (2013)
Upregulation of microRNA-203 is associated with advanced tumor progression and poor prognosis in epithelial ovarian cancer
Shaosheng Wang et al.
MEDICAL ONCOLOGY (2013)
Identification of Ovarian Cancer Metastatic miRNAs
Souriya Vang et al.
PLOS ONE (2013)
Stem Cell-Like Gene Expression in Ovarian Cancer Predicts Type II Subtype and Prognosis
Matthew Schwede et al.
PLOS ONE (2013)
Plasma miRNAs as Diagnostic and Prognostic Biomarkers for Ovarian Cancer
Hong Zheng et al.
PLOS ONE (2013)
A microRNA signature defines chemoresistance in ovarian cancer through modulation of angiogenesis
Andrea Vecchione et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Expression of M2-Polarized Macrophages is Associated with Poor Prognosis for Advanced Epithelial Ovarian Cancer
Chunyan Lan et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2013)
Therapeutic Synergy between microRNA and siRNA in Ovarian Cancer Treatment
Masato Nishimura et al.
CANCER DISCOVERY (2013)
The use of HE4, CA125 and CA72-4 biomarkers for differential diagnosis between ovarian endometrioma and epithelial ovarian cancer
Emanuela Anastasi et al.
JOURNAL OF OVARIAN RESEARCH (2013)
Downregulation of miRNA-31 induces taxane resistance in ovarian cancer cells through increase of receptor tyrosine kinase MET
T. Mitamura et al.
ONCOGENESIS (2013)
Serum HE4 levels are less frequently elevated than CA125 in women with benign gynecologic disorders
Richard G. Moore et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2012)
Elevated levels of circulating microRNA-200 family members correlate with serous epithelial ovarian cancer
Casina W. S. Kan et al.
BMC CANCER (2012)
Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancer
V. Abkevich et al.
BRITISH JOURNAL OF CANCER (2012)
The epidermal growth factor receptor as a therapeutic target in epithelial ovarian cancer
Ting Gui et al.
CANCER EPIDEMIOLOGY (2012)
Ovarian cancer stem cell markers: Prognostic and therapeutic implications
Daniela Burgos-Ojeda et al.
CANCER LETTERS (2012)
Monocytic CCR2+ Myeloid-Derived Suppressor Cells Promote Immune Escape by Limiting Activated CD8 T-cell Infiltration into the Tumor Microenvironment
Alexander M. Lesokhin et al.
CANCER RESEARCH (2012)
CD20+ Tumor-Infiltrating Lymphocytes Have an Atypical CD27- Memory Phenotype and Together with CD8+ T Cells Promote Favorable Prognosis in Ovarian Cancer
Julie S. Nielsen et al.
CLINICAL CANCER RESEARCH (2012)
Tumor-derived microvesicles: shedding light on novel microenvironment modulators and prospective cancer biomarkers
Crislyn D'Souza-Schorey et al.
GENES & DEVELOPMENT (2012)
Serum HE4 concentration is not dependent on menstrual cycle or hormonal treatment among endometriosis patients and healthy premenopausal women
M. Hallamaa et al.
GYNECOLOGIC ONCOLOGY (2012)
Prognostic and diagnostic significance of DNA methylation patterns in high grade serous ovarian cancer
Celine Montavon et al.
GYNECOLOGIC ONCOLOGY (2012)
17β hydroxysteroid dehydrogenase type 12 (HSD17B12) is a marker of poor prognosis in ovarian carcinoma
Marta Szajnik et al.
GYNECOLOGIC ONCOLOGY (2012)
Evaluation of HE4, CA125, risk of ovarian malignancy algorithm (ROMA) and risk of malignancy index (RMI) as diagnostic tools of epithelial ovarian cancer in patients with a pelvic mass
Mona Aarenstrup Karlsen et al.
GYNECOLOGIC ONCOLOGY (2012)
Differential Diagnosis of a Pelvic Mass Improved Algorithms and Novel Biomarkers
Robert C. Bast et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2012)
The tumor microenvironment at a glance
Frances R. Balkwill et al.
JOURNAL OF CELL SCIENCE (2012)
Publication of Tumor Marker Research Results: The Necessity for Complete and Transparent Reporting
Lisa M. McShane et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Absolute lymphocyte count is associated with survival in ovarian cancer independent of tumor-infiltrating lymphocytes
Katy Milne et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
CD133 expression associated with poor prognosis in ovarian cancer
Jing Zhang et al.
MODERN PATHOLOGY (2012)
Safety and Activity of Anti-PD-L1 Antibody in Patients with Advanced Cancer
Julie R. Brahmer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Regulation of ovarian cancer progression by microRNA-187 through targeting Disabled homolog-2
A. Chao et al.
ONCOGENE (2012)
Prognostic implications of microRNA-100 and its functional roles in human epithelial ovarian cancer
Dong-Xian Peng et al.
ONCOLOGY REPORTS (2012)
BTN3A2 Expression in Epithelial Ovarian Cancer Is Associated with Higher Tumor Infiltrating T Cells and a Better Prognosis
Cecile Le Page et al.
PLOS ONE (2012)
Tumor-infiltrating B cells and T cells Working together to promote patient survival
Julie S. Nielsen et al.
ONCOIMMUNOLOGY (2012)
Papillary Tubal Hyperplasia: The Putative Precursor of Ovarian Atypical Proliferative (Borderline) Serous Tumors, Noninvasive Implants, and Endosalpingiosis
Robert J. Kurman et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2011)
Identification of Hydroxysteroid (17β) dehydrogenase type 12 (HSD17B12) as a CD8+ T-cell-defined human tumor antigen of human carcinomas
Carmen Visus et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
Using a Stem Cell-Based Signature to Guide Therapeutic Selection in Cancer
Igor Shats et al.
CANCER RESEARCH (2011)
Quantitative and Functional Alterations of Plasmacytoid Dendritic Cells Contribute to Immune Tolerance in Ovarian Cancer
Sana Intidhar Labidi-Galy et al.
CANCER RESEARCH (2011)
PGE2-Induced CXCL12 Production and CXCR4 Expression Controls the Accumulation of Human MDSCs in Ovarian Cancer Environment
Natasa Obermajer et al.
CANCER RESEARCH (2011)
Systematic CpG Islands Methylation Profiling of Genes in the Wnt Pathway in Epithelial Ovarian Cancer Identifies Biomarkers of Progression-Free Survival
Wei Dai et al.
CLINICAL CANCER RESEARCH (2011)
The miR-200 family controls β-tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients
Susanna Leskelae et al.
ENDOCRINE-RELATED CANCER (2011)
Osteopontin: a potentially important therapeutic target in cancer
Mansoor Ahmed et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2011)
Epigenetic suppression of the TGF-beta pathway revealed by transcriptome profiling in ovarian cancer
Noriomi Matsumura et al.
GENOME RESEARCH (2011)
Distinctive DNA methylation patterns of cell-free plasma DNA in women with malignant ovarian tumors
Thomas E. Liggett et al.
GYNECOLOGIC ONCOLOGY (2011)
A microRNA survival signature (MiSS) for advanced ovarian cancer
Karin K. Shih et al.
GYNECOLOGIC ONCOLOGY (2011)
Antigen-Presenting Cell (APC) Subsets in Ovarian Cancer
Cailin Moira Wilke et al.
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2011)
Cancer stem cell hypotheses: Impact on modern molecular physiology and pharmacology research
Igor Pantic
JOURNAL OF BIOSCIENCES (2011)
Association between miR-200c and the survival of patients with stage I epithelial ovarian cancer: a retrospective study of two independent tumour tissue collections
Sergio Marchini et al.
LANCET ONCOLOGY (2011)
Integrated genomic analyses of ovarian carcinoma
D. Bell et al.
NATURE (2011)
MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins
Kasey C. Vickers et al.
NATURE CELL BIOLOGY (2011)
Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma
Jason D. Arroyo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Microvesicles are messengers
Juerg A. Schifferli
SEMINARS IN IMMUNOPATHOLOGY (2011)
Prevalence of Epithelial Ovarian Cancer Stem Cells Correlates with Recurrence in Early-Stage Ovarian Cancer
Karina Dahl Steffensen et al.
JOURNAL OF ONCOLOGY (2011)
Whole blood-derived miRNA profiles as potential new tools for ovarian cancer screening
S. F. M. Haeusler et al.
BRITISH JOURNAL OF CANCER (2010)
Plasma Cell-Free DNA in Ovarian Cancer An Independent Prognostic Biomarker
Aparna A. Kamat et al.
CANCER (2010)
Microparticles Protagonists of a Novel Communication Network for Intercellular Information Exchange
Sebastian F. Mause et al.
CIRCULATION RESEARCH (2010)
MiR-221 and MiR-222 Alterations in Sporadic Ovarian Carcinoma: Relationship to CDKN1B, CDKN1C and Overall Survival
Kaitlyn Wurz et al.
GENES CHROMOSOMES & CANCER (2010)
Frequent promoter hypermethylation of TGFBI in epithelial ovarian cancer
Sokbom Kang et al.
GYNECOLOGIC ONCOLOGY (2010)
Epigenetic silencing of SFRP5 is related to malignant phenotype and chemoresistance of ovarian cancer through Wnt signaling pathway
Her-Young Su et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Gene Expression Profile of BRCAness That Correlates With Responsiveness to Chemotherapy and With Outcome in Patients With Epithelial Ovarian Cancer
Panagiotis A. Konstantinopoulos et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Promoter hypermethylation of FBXO32, a novel TGF-β/SMAD4 target gene and tumor suppressor, is associated with poor prognosis in human ovarian cancer
Jian-Liang Chou et al.
LABORATORY INVESTIGATION (2010)
Targeting Aldehyde Dehydrogenase Cancer Stem Cells in Ovarian Cancer
Charles N. Landen et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Distinct Expression Levels and Patterns of Stem Cell Marker, Aldehyde Dehydrogenase Isoform 1 (ALDH1), in Human Epithelial Cancers
Shan Deng et al.
PLOS ONE (2010)
Tumor-Derived Microvesicles Induce, Expand and Up-Regulate Biological Activities of Human Regulatory T Cells (Treg)
Marta Szajnik et al.
PLOS ONE (2010)
Overexpression of Elafin in Ovarian Carcinoma Is Driven by Genomic Gains and Activation of the Nuclear Factor κB Pathway and Is Associated with Poor Overall Survival
Adam Clauss et al.
NEOPLASIA (2010)
High mesothelin correlates with chemoresistance and poor survival in epithelial ovarian carcinoma
W-F Cheng et al.
BRITISH JOURNAL OF CANCER (2009)
Utility of Gene Promoter Methylation in Prediction of Response to Platinum-Based Chemotherapy in Epithelial Ovarian Cancer (EOC)
Parvesh Chaudhry et al.
CANCER INVESTIGATION (2009)
MicroRNAs: Novel regulators in the hallmarks of human cancer
Kai Ruan et al.
CANCER LETTERS (2009)
Membrane Microvesicles as Actors in the Establishment of a Favorable Prostatic Tumoral Niche: A Role for Activated Fibroblasts and CX3CL1-CX3CR1 Axis
Donatello Castellana et al.
CANCER RESEARCH (2009)
IRX-2, a novel immunotherapeutic, protects human T cells from tumor-induced cell death
M. Czystowska et al.
CELL DEATH AND DIFFERENTIATION (2009)
Epigenetic Changes in Ovarian Cancer
Curt Balch et al.
ENDOCRINOLOGY (2009)
A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer
Xiaoxia Hu et al.
GYNECOLOGIC ONCOLOGY (2009)
A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass
Richard G. Moore et al.
GYNECOLOGIC ONCOLOGY (2009)
The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform
Kimberly E. Resnick et al.
GYNECOLOGIC ONCOLOGY (2009)
An epigenetic marker panel for screening and prognostic prediction of ovarian cancer
Her-Young Su et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
miR-29b Expression Is Associated With Disease-Free Survival in Patients With Ovarian Serous Carcinoma
Richard Flavin et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2009)
Tumor-Derived Microvesicles Promote Regulatory T Cell Expansion and Induce Apoptosis in Tumor-Reactive Activated CD8+ T Lymphocytes
Eva U. Wieckowski et al.
JOURNAL OF IMMUNOLOGY (2009)
ALDH1 expression correlates with favorable prognosis in ovarian cancers
Bin Chang et al.
MODERN PATHOLOGY (2009)
Screening for Ovarian Cancer
Daniel L. Clarke-Pearson
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Detection of M2 macrophages and colony-stimulating factor 1 expression in serous and mucinous ovarian epithelial tumors
Kyoko Kawamura et al.
PATHOLOGY INTERNATIONAL (2009)
Aberrant Promoter Methylation of Sparc in Ovarian Cancer
Matthew J. Socha et al.
NEOPLASIA (2009)
Phenotypic and Functional Delineation of Murine CX3CR1+ Monocyte-Derived Cells in Ovarian Cancer
Kevin M. Hart et al.
NEOPLASIA (2009)
Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalities
Joshua Z. Press et al.
BMC CANCER (2008)
Diagnostic markers for early detection of ovarian cancer
Irene Visintin et al.
CLINICAL CANCER RESEARCH (2008)
T regulatory type 1 cells in squamous cell carcinoma of the head and neck: Mechanisms of suppression and expansion in advanced disease
Christoph Bergmann et al.
CLINICAL CANCER RESEARCH (2008)
MicroRNA expression profiles in serous ovarian carcinoma
Eun Ji Nam et al.
CLINICAL CANCER RESEARCH (2008)
被撤回的出版物: MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer (Retracted article. See vol. 175, pg. 192, 2023)
Douglas D. Taylor et al.
GYNECOLOGIC ONCOLOGY (2008)
Prognostic significance of CD3+ tumor-infiltrating lymphocytes in ovarian carcinoma
Marketa Tomsova et al.
GYNECOLOGIC ONCOLOGY (2008)
The impact of T-cell immunity on ovarian cancer outcomes
Brad H. Nelson
IMMUNOLOGICAL REVIEWS (2008)
Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers
Johan Skog et al.
NATURE CELL BIOLOGY (2008)
An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors
Ittai Ben-Porath et al.
NATURE GENETICS (2008)
Levels of circulating cell-free nuclear and mitochondrial DNA in benign and malignant ovarian tumors
Rebecca R. Zachariah et al.
OBSTETRICS AND GYNECOLOGY (2008)
Detection and Characterization of CD133+ Cancer Stem Cells in Human Solid Tumours
Virginia Tirino et al.
PLOS ONE (2008)
Clinical and biological significance of HLA-G expression in ovarian cancer
Jim Jinn-Chyuan Sheu et al.
SEMINARS IN CANCER BIOLOGY (2007)
Methylation profile in benign, borderline and malignant ovarian tumors
K. F. Tam et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2007)
Tumor-released microvesicles as vehicles of immunosuppression
Roberta Valenti et al.
CANCER RESEARCH (2007)
Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse
Gaynor J. Bates et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Circulating cell-free DNA - A novel biomarker for response to therapy in ovarian carcinoma
Aparna A. Kamat et al.
CANCER BIOLOGY & THERAPY (2006)
Insulin-like growth factor-binding protein 2 and 5 are differentially regulated in ovarian cancer of different histologic types
Huamin Wang et al.
MODERN PATHOLOGY (2006)
Differential DNA methylation profiles in gynecological cancers and correlation with clinico-pathological data
Hui-Juan Yang et al.
BMC CANCER (2006)
Aberrant promoter methylation of multiple genes in malignant ovarian tumors and in ovarian tumors with low malignant potential
Andrew Wiley et al.
CANCER (2006)
BRCA1 promoter methylation predicts adverse ovarian cancer prognosis
Jing Wang Chiang et al.
GYNECOLOGIC ONCOLOGY (2006)
Preoperative plasma osteopontin level as a biomarker complementary to carbohydrate antigen 125 in predicting ovarian cancer
Mitsuhiro Nakae et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (2006)
Prognostic DNA methylation biomarkers in ovarian cancer
SH Wei et al.
CLINICAL CANCER RESEARCH (2006)
B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma
I Kryczek et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction?
SB Baylin et al.
NATURE REVIEWS CANCER (2006)
Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer
E Sato et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Abnormal lysosomal trafficking and export of cisplatin in drug-resistant ovarian carcinoma cells
R Safaei et al.
MOLECULAR CANCER THERAPEUTICS (2005)
Characterization of macrophage subpopulations in colon cancer using tissue microarrays
D Sickert et al.
HISTOPATHOLOGY (2005)
Soluble epidermal growth factor receptor (SEG-FR) and cancer antigen 125 (CA125) as screening and diagnostic tests for epithelial ovarian cancer
AT Baron et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2005)
Proinvasive properties of ovarian cancer ascites-derived membrane vesicles
LE Graves et al.
CANCER RESEARCH (2004)
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
TJ Curiel et al.
NATURE MEDICINE (2004)
DNA hypomethylation and ovarian cancer biology
M Widschwendter et al.
CANCER RESEARCH (2004)
The acquisition of hMLH1 methylation in plasma DNA after chemotherapy predicts poor survival for ovarian cancer patients
G Gifford et al.
CLINICAL CANCER RESEARCH (2004)
Effect of proton pump inhibitor pretreatment on resistance of solid tumors to cytotoxic drugs
F Luciani et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
Phase III randomized trial of docetaxel-carboplatin versus paclitaxel-carboplatin as first-line chemotherapy for ovarian carcinoma
PA Vasey et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
Preoperative sensitivity and specificity for early-stage ovarian cancer when combining cancer antigen CA-125II, CA 15-3, CA 72-4, and macrophage colony-stimulating factor using mixtures of multivariate normal distributions
SJ Skates et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Ovarian tumorigenesis - A proposed model based on morphological and molecular genetic analysis
IM Shih et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
OPCML at 11q25 is epigenetically inactivated and has tumor-suppressor function in epithelial ovarian cancer
GC Sellar et al.
NATURE GENETICS (2003)
CD24 is expressed in ovarian cancer and is a new independent prognostic marker of patient survival
G Kristiansen et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Use of proteomic patterns in serum to identify ovarian cancer
EF Petricoin et al.
LANCET (2002)
Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells:: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance
S Sakaguchi et al.
IMMUNOLOGICAL REVIEWS (2001)
Share Paper
